![Karin Agerman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Karin Agerman worked as the Chief Research & Development Officer at CombiGene AB from 2018 to 2024.
She holds a doctorate degree from Karolinska Institutet.
Anciens postes connus de Karin Agerman
| Sociétés | Poste | Fin |
|---|---|---|
| COMBIGENE AB | Directeur Technique/Scientifique/R&D | 27/05/2024 |
Formation de Karin Agerman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
11
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Karolinska Institutet
 Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CombiGene AB
 CombiGene AB Pharmaceuticals: MajorHealth Technology Develops and commercializes gene therapy for treatment of neurological and psychiatric disorders | Health Technology |
